Bruce Kramer participated in a drug trial to determine if Dexpramipexole could slow the progression of ALS.
Kramer felt the drug was working for him and was frustrated when the trial was terminated.
MPR News is Member Supported
What does that mean? The news, analysis and community conversation found here is funded by donations from individuals. Make a gift of any amount during the Winter Member Drive to support this resource for everyone.